title: Eradication of JAK2 V617F mutation after allogeneic transplantation in a patient with myelofibrosis with myeloid metaplasia.
authors.forename: A
authors.initials: A
authors.lastname: Fiorini
authors.forename: G
authors.initials: G
authors.lastname: Reddiconto
authors.forename: G
authors.initials: G
authors.lastname: Farina
authors.forename: S
authors.initials: S
authors.lastname: Marietti
authors.forename: M
authors.initials: M
authors.lastname: Palladino
authors.forename: P
authors.initials: P
authors.lastname: Chiusolo
authors.forename: G
authors.initials: G
authors.lastname: Leone
authors.forename: S
authors.initials: S
authors.lastname: Sica
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D055728:Primary Myelofibrosis / Q000235:genetics* / Q000628:therapy; D014184:Transplantation, Homologous
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2